ATE476666T1 - Verfahren zur identifizierung von glykoformspezifischen antikörpern - Google Patents

Verfahren zur identifizierung von glykoformspezifischen antikörpern

Info

Publication number
ATE476666T1
ATE476666T1 AT05701355T AT05701355T ATE476666T1 AT E476666 T1 ATE476666 T1 AT E476666T1 AT 05701355 T AT05701355 T AT 05701355T AT 05701355 T AT05701355 T AT 05701355T AT E476666 T1 ATE476666 T1 AT E476666T1
Authority
AT
Austria
Prior art keywords
glycoform
glycoprotein
state
determined
specific antibodies
Prior art date
Application number
AT05701355T
Other languages
English (en)
Inventor
Catherine Ronin
Sandrine Donadio
Original Assignee
Centre Nat Rech Scient
Univ Provence Aix Marseille 1
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Univ Provence Aix Marseille 1 filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE476666T1 publication Critical patent/ATE476666T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT05701355T 2004-02-04 2005-02-04 Verfahren zur identifizierung von glykoformspezifischen antikörpern ATE476666T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04290290 2004-02-04
PCT/EP2005/001160 WO2005076013A2 (en) 2004-02-04 2005-02-04 Process for screening glycoform-specific antibodies

Publications (1)

Publication Number Publication Date
ATE476666T1 true ATE476666T1 (de) 2010-08-15

Family

ID=34833783

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05701355T ATE476666T1 (de) 2004-02-04 2005-02-04 Verfahren zur identifizierung von glykoformspezifischen antikörpern

Country Status (8)

Country Link
US (1) US8431355B2 (de)
EP (1) EP1711834B1 (de)
AT (1) ATE476666T1 (de)
CA (1) CA2554968C (de)
DE (1) DE602005022675D1 (de)
DK (1) DK1711834T3 (de)
ES (1) ES2350298T3 (de)
WO (1) WO2005076013A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006331619B2 (en) 2005-12-23 2012-12-20 James D. Kelly Improved thyroid-stimulating hormone receptor polypeptide agonist glycoforms to treat metabolic syndrome
US20070218503A1 (en) * 2006-02-13 2007-09-20 Mitra Robi D Methods of polypeptide identification, and compositions therefor
US7879799B2 (en) 2006-08-10 2011-02-01 Institute For Systems Biology Methods for characterizing glycoproteins and generating antibodies for same
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI532495B (zh) 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
EP2691119B1 (de) 2011-03-31 2018-08-01 Ferring B.V. Pharmazeutische zubereitung
WO2014052360A2 (en) * 2012-09-26 2014-04-03 Momenta Pharmaceuticals, Inc. Glycoprotein preparations
EP3004368B1 (de) * 2013-05-29 2019-09-18 F.Hoffmann-La Roche Ag Quantitative steuerung von sialylierung
CA2911965C (en) * 2013-07-05 2018-06-19 F. Hoffmann-La Roche Ag Process for the mono- and bi-sialylation of glycoproteins employing n-terminally truncated beta-galactoside alpha-2,6-sialyltransferase mutants
EP2824176A1 (de) 2013-07-11 2015-01-14 Siamed'xpress Verfahren zur Herstellung von sialylierten therapeutischen Proteinen
JP2018500934A (ja) 2014-12-22 2018-01-18 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Ｃｍｐ依存性シアリダーゼ活性
EP3037527A1 (de) * 2014-12-22 2016-06-29 F. Hoffmann-La Roche AG Sialyltransferase ohne CMP-abhängige Sialidaseaktivität
CN113960232B (zh) * 2021-10-28 2024-02-20 苏州大学 一种基于唾液特异性岩藻糖基化结构糖谱及其检测方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976876A (en) * 1995-12-11 1999-11-02 The Trustees Of Columbia University In The City Of New York Antibodies specific for hLH β core fragment
WO1999039202A1 (en) * 1998-02-03 1999-08-05 The Trustees Of Columbia University In The City Of New York DETERMINATION OF THE AMOUNT OF hLHβ CORE FRAGMENT IN A SAMPLE FROM A SUBJECT AND USES THEREOF
US6528269B1 (en) 1998-06-22 2003-03-04 Case Western Reserve University Immunological agents specific for prion protein (PRP)
EP1143250A3 (de) * 2000-04-03 2004-11-17 Inverness Medical Switzerland GmbH Testverfahren und Vorrichtungen für Analytisoformen

Also Published As

Publication number Publication date
WO2005076013B1 (en) 2007-03-08
WO2005076013A3 (en) 2005-12-08
DE602005022675D1 (de) 2010-09-16
WO2005076013A2 (en) 2005-08-18
DK1711834T3 (da) 2010-11-29
US8431355B2 (en) 2013-04-30
CA2554968C (en) 2012-03-27
US20080199892A1 (en) 2008-08-21
CA2554968A1 (en) 2005-08-18
EP1711834A2 (de) 2006-10-18
EP1711834B1 (de) 2010-08-04
ES2350298T3 (es) 2011-01-20

Similar Documents

Publication Publication Date Title
ATE476666T1 (de) Verfahren zur identifizierung von glykoformspezifischen antikörpern
NL300919I2 (nl) Brodalumab
NZ717847A (en) Human antigen binding proteins that bind beta-klotho, fgf receptors and complexes thereof
ATE511656T1 (de) Verfahren zur risikobewertung von herzeingriffen auf gdf-15-basis
WO2006061723A3 (en) Human monoclonal antibodies to influenza m2 protein and methods of making and using same
UA94576C2 (ru) Выделенное антитело, которое связывается с igf-1r, композиция, которая его содержит, и способы, которые касаются антител
DE60223058D1 (de) Zusammensetzungen und verfahren zur behandlung von diabetes
WO2007001459A3 (en) Compositions and methods for modulating lymphocyte activity
NZ584838A (en) Novel antibodies which bind alpha5beta1 (fibronectin receptor) and uses thereof
WO2003078600A3 (en) Human monoclonal antibodies to influenza m2 protein and methods of making and using same
ATE430198T1 (de) Antikörperkonstruktion unter verwendung einer mrl/lpr-maus
DE602004030621D1 (de) Verfahren und Vorrichtung zur Erzeugung von zusammengesetzen Benutzeroberflächen
ATE425896T1 (de) Benutzeradaptives system zur automatischen kontrolle von fahrzeugen
ATE524561T1 (de) Verfahren zur bestimmung einer allergenreaktion unter verwendung von mikroarray-immunoassay- techniken
ATE505535T1 (de) Verfahren zur herstellung stabiler b-lymphozyten
ATE482398T1 (de) Verfahren zur stratifizierung von herzinsuffizienz
WO2003062943A3 (en) Method for analyzing data to identify network motifs
DE602006010934D1 (de) Verfahren zur Identifizierung von Epitopen in Zusammenhang mit Immunogenität bei Biopharmazeutika
WO2008110593A3 (de) Verfahren und marker zur diagnose von nierenerkrankungen
EP1412388A4 (de) Von dd 3b6/22 abgeleitete humanisierte antikörper mit spezifität für das d-dimer fragment von fibrin
WO2010079076A3 (de) Autosomal dominante polyzystische nierenerkrankung (adpkd)
ATE532072T1 (de) Verfahren und vorrichtung zur beurteilung von polypeptidaggregation
WO2011029954A3 (de) Polypeptidmarker zur diagnostik und beurteilung vaskulärer erkrankungen
ATE533055T1 (de) Verfahren zum screenen mithilfe von konformationsempfindlichen peptiden
WO2008081331A3 (en) Enhancing the level of antibody expression by framework re-engineering

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties